References
- GiraudeauCGeffroyFMeriauxS19F molecular MR imaging for detection of brain tumor angiogenesis: in vivo validation using targeted PFOB nanoparticlesAngiogenesis201316117117923053783
- WolfsonMRGreenspanJSShafferTHLiquid-assisted ventilation: an alternative respiratory modalityPediatr Pulmonol199826142639710279
- ObraztsovVVGrishanovaAShekhtmanDGSklifasANMakarovKNInteraction of perfluoroctylbromide with liver microsomal monooxygenaseBiokhimiia1993588123412398399771
- LongDMLongDCMattreyRFAn overview of perfluoroctyl-bromide – application as a synthetic oxygen carrier and imaging agent for X-ray, ultrasound and nuclear magnetic resonanceBiomater Artif Cells Artif Organs1988161–34114203052645
- EllenaJFObraztsovVVCumbeaVLWoodsCMCafisoDSPerfluorooctyl bromide has limited membrane solubility and is located at the bilayer center. Locating small molecules in lipid bilayers through paramagnetic enhancements of NMR relaxationJ Med Chem200245255534554212459021
- KrafftMPFluorocarbons and fluorinated amphiphiles in drug delivery and biomedical researchAdv Drug Deliver Rev2001472–3209228
- WangKHuangQQiuFSuiMNon-viral delivery systems for the application in p53 cancer gene therapyCurr Med Chem201522354118413626423086
- ZhangBWangKSiJSuiMShenYCharge-reversal polymers for biodeliveryGuZBioinspired and Biomimetic Polymer Systems for Drug and Gene DeliveryWeinheim, GermanyWiley-VCH Verlag GmbH & Co. KGaA2014223242
- PisaniETsapisNGalazBBridalSLFattalEPerfluorooctyl bromide polymeric capsules as dual contrast agents for ultrasonography and magnetic resonance imagingAdv Funct Mater2008181929632971
- WakabayashiTTamuraMNakamuraTPartial liquid ventilation with low-dose perfluorochemical and high-frequency oscillation improves oxygenation and lung compliance in a rabbit model of surfactant depletionBiol Neonate200689317718216219999
- RiessJGPerfluorocarbon-based oxygen deliveryArtif Cells Blood Substit Immobil Biotechnol200634656758017090429
- JacobyCTemmeSMayenfelsFProbing different perfluorocarbons for in vivo inflammation imaging by 19F MRI: image reconstruction, biological half-lives and sensitivityNMR Biomed201427326127124353148
- GoetteMJKeuppJRahmerJLanzaGMWicklineSACaruthersSDBalanced UTE-SSFP for 19F MR imaging of complex spectraMagn Reson Med201574253754325163853
- SchmiederAHWangKZhangHCharacterization of early neovascular response to acute lung ischemia using simultaneous (19) F/(1)H MR molecular imagingAngiogenesis2014171516023918207
- MorawskiAMWinterPMYuXQuantitative “magnetic resonance immunohistochemistry” with ligand-targeted (19)F nanoparticlesMagn Reson Med20045261255126215562481
- WatersEAChenJYangXDetection of targeted perfluorocarbon nanoparticle binding using 19F diffusion weighted MR spectroscopyMagn Reson Med20086051232123618956417
- Vu-QuangHVindingMSNielsenTUllischMGNielsenNCKjemsJTheranostic tumor targeted nanoparticles combining drug delivery with dual near infrared and 19F magnetic resonance imaging modalitiesNanomedicine20161271873188427133191
- GiraudeauCDjemaiBGhalyMAHigh sensitivity 19F MRI of a perfluorooctyl bromide emulsion: application to a dynamic biodistribution study and oxygen tension mapping in the mouse liver and spleenNMR Biomed201225465466021953998
- DiouOTsapisNGiraudeauCLong-circulating perfluorooctyl bromide nanocapsules for tumor imaging by 19FMRIBiomaterials201233225593560222575831
- PartlowKCChenJBrantJA19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeaconsFASEB J20072181647165417284484
- BarnettBPRuiz-CabelloJHotaPUse of perfluorocarbon nanoparticles for non-invasive multimodal cell tracking of human pancreatic isletsMol Imaging201164251259
- AhrensETFloresRXuHMorelPAIn vivo imaging platform for tracking immunotherapeutic cellsNat Biotechnol200523898398716041364
- HillMLGorelikovINirouiFTowards a nanoscale mammographic contrast agent: development of a modular pre-clinical dual optical/x-ray agentPhys Med Biol201358155215523523851978
- MattreyRFBrownJJSheltonREOginoMTJohnsonKKMittenRMUse of perfluorooctylbromide (PFOB) to detect liver abscesses with computed tomography. Safety and efficacyInvest Radiol19912697927981938289
- LiuZLammersTEhlingJIron oxide nanoparticle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imagingBiomaterials201132266155616321632103
- MattreyRFScheibleFWGosinkBBLeopoldGRLongDMHigginsCBPerfluoroctylbromide: a liver/spleen-specific and tumor- imaging ultrasound contrast materialRadiology198214537597627146409
- LanzaGMWallaceKDScottMJA novel site-targeted ultrasonic contrast agent with broad biomedical applicationCirculation19969412333433408989148
- JafariSDiouOMamouJHigh-frequency (20 to 40 MHz) acoustic response of liquid-filled nanocapsulesIEEE Trans Ultrason Ferroelectr Freq Control201461151524402891
- MarshJNHallCSScottMJImprovements in the ultrasonic contrast of targeted perfluorocarbon nanoparticles using an acoustic transmission line modelIEEE Trans Ultrason Ferroelectr Freq Control2002491293811833889
- WicklineSAHughesMNgoFCBlood contrast enhancement with a novel, non-gaseous nanoparticle contrast agentAcad Radiol20029suppl 2S290S29312188251
- Diaz-LopezRTsapisNFattalELiquid perfluorocarbons as contrast agents for ultrasonography and (19)F-MRIPharm Res201027111619902338
- ZhouHFChanHWWicklineSALanzaGMPhamCTAlphavbeta3-targeted nanotherapy suppresses inflammatory arthritis in miceFASEB J20092392978298519376816
- LiXQinFYangLMoLLiLHouLSulfatide-containing lipid perfluorooctylbromide nanoparticles as paclitaxel vehicles targeting breast carcinomaInt J Nanomedicine201493971398525170267
- MorawskiAMWinterPMCrowderKCTargeted nanoparticles for quantitative imaging of sparse molecular epitopes with MRIMagn Reson Med200451348048615004788
- RossiMUse of lecithin and lecithin fractionsIn BioactiVe Egg Compounds200734229239
- KeipertPEOttoSFlaimSFInfluence of perflubron emulsion particle size on blood half-life and febrile response in ratsArtif Cells Blood Substit Immobil Biotechnol1994224116911747849919
- Diaz-LopezRTsapisNLibongDPhospholipid decoration of microcapsules containing perfluorooctyl bromide used as ultrasound contrast agentsBiomaterials20093081462147219097640
- Diaz-LopezRLibongDTsapisNFattalEChaminadePQuantification of pegylated phospholipids decorating polymeric microcapsules of perfluorooctyl bromide by reverse phase HPLC with a charged aerosol detectorJ Pharm Biomed Anal200848370270718818041
- KeHYueXWangJGold nanoshelled liquid perfluorocarbon nanocapsules for combined dual modal ultrasound/CT imaging and photothermal therapy of cancerSmall20141061220122724500926
- FleggMBPooleCMWhittakerAKKeenILangtonCMRayleigh theory of ultrasound scattering applied to liquid-filled contrast nanoparticlesPhys Med Biol201055113061307620463372
- PisaniEFattalEParisJRingardCRosilioVTsapisNSurfactant dependent morphology of polymeric capsules of perfluorooctyl bromide: influence of polymer adsorption at the dichloromethane-water interfaceJ Colloid Interface Sci20083261667118674774
- MakadiaHKSiegelSJPoly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrierPolymers (Basel)2011331377139722577513
- ShiveMSAndersonJMBiodegradation and biocompatibility of PLA and PLGA microspheresAdv Drug Deliv Rev199728152410837562
- LiHWangPWangXPerfluorooctyl bromide traces self-assembled with polymeric nanovesicles for blood pool ultrasound imagingBiomater Sci20164697998827121357
- PodellSBurrascanoCGaalMGolecBManiquisJMehlhaffPPhysical and biochemical stability of Optison, an injectable ultrasound contrast agentBiotechnol Appl Biochem199930pt 321322310574690
- KitzmanDWGoldmanMEGillamLDCohenJLAurigemmaGPGottdienerJSEfficacy and safety of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline left ventricular echocardiographic imagesAm J Cardiol200086666967410980221
- YuanFDellianMFukumuraDVascular permeability in a human tumor xenograft: molecular size dependence and cutoff sizeCancer Res19955517375237567641188
- HughesMSMarshJNHallCSAcoustic characterization in whole blood and plasma of site-targeted nanoparticle ultrasound contrast agent for molecular imagingJ Acoust Soc Am2005117296497215759715
- FosterFSPavlinCJHarasiewiczKAChristopherDATurnbullDHAdvances in ultrasound biomicroscopyUltrasound Med Biol200026112710687788
- FosterFSZhangMYZhouYQA new ultrasound instrument for in vivo microimaging of miceUltrasound Med Biol20022891165117212401387
- Mor-AviVLangRMRecent advances in echocardiographic evaluation of left ventricular anatomy, perfusion, and functionCardiol Rev20019314615911304400
- LiZKeHWangJMiaoZYueXGraphene oxide and gadolinium-chelate functionalized poly(lactic acid) nanocapsules encapsulating perfluorooctylbromide for ultrasound/magnetic resonance bimodal imaging guided photothermal ablation of cancerJ Nanosci Nanotechnol20161632201220927455619
- PisaniETsapisNParisJNicolasVCattelLFattalEPolymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: physical characterizationLangmuir20062294397440216618193
- DiouOBruletAPehau-ArnaudetGPEGylated nanocapsules of perfluorooctyl bromide: mechanism of formation, influence of polymer concentration on morphology and mechanical propertiesColloids Surf B Biointerfaces201614676276927451363
- HaiatGBertiRGalazBTaulierNAmmanJJUrbachWTwo-dimensional simulation of linear wave propagation in a suspension of polymeric microcapsules used as ultrasound contrast agentsJ Acoust Soc Am201112931642165221428527
- BarnettBPRuiz-CabelloJHotaPFluorocapsules for improved function, immunoprotection, and visualization of cellular therapeutics with MR, US, and CT imagingRadiology2011258118219120971778
- ZhaZWangJZhangSEngineering of perfluorooctylbromide polypyrrole nano-/microcapsules for simultaneous contrast enhanced ultrasound imaging and photothermal treatment of cancerBiomaterials201435128729324120049
- KeHWangJTongSGold nanoshelled liquid perfluorocarbon magnetic nanocapsules: a nanotheranostic platform for bimodal ultrasound/magnetic resonance imaging guided photothermal tumor ablationTheranostics201341122324396512
- LiAZhengYYuJSuperparamagnetic perfluorooctylbromide nanoparticles as a multimodal contrast agent for US, MR, and CT imagingActa Radiol201354327828323319724
- NolteIVinceGHMaurerMIron particles enhance visualization of experimental gliomas with high-resolution sonographyAJNR Am J Neuroradiol20052661469147415956517
- MarshJNPartlowKCAbendscheinDRScottMJLanzaGMWicklineSAMolecular imaging with targeted perfluorocarbon nanoparticles: quantification of the concentration dependence of contrast enhancement for binding to sparse cellular epitopesUltrasound Med Biol200733695095817434667
- KobayashiHTurkbeyBWatanabeRChoykePLCancer drug delivery: considerations in the rational design of nanosized bioconjugatesBioconjug Chem201425122093210025385142
- HughesMSMarshJNArbeitJMApplication of Renyi entropy for ultrasonic molecular imagingJ Acoust Soc Am200912553141314519425656
- Diaz-LopezRTsapisNSantinMThe performance of PEGylated nanocapsules of perfluorooctyl bromide as an ultrasound contrast agentBiomaterials20103171723173119948357
- ZhaoRMatherlyLHGoldmanIDMembrane transporters and folate homeostasis: intestinal absorption and transport into systemic compartments and tissuesExpert Rev Mol Med200911e419173758
- KaneMAThe role of folates in squamous cell carcinoma of the head and neckCancer Detect Prev2005291465315734217
- HartmannLCKeeneyGLLingleWLFolate receptor overexpression is associated with poor outcome in breast cancerInt J Cancer2007121593894217487842
- O’ShannessyDJYuGSmaleRFolate receptor alpha expression in lung cancer: diagnostic and prognostic significanceOncotarget20123441442522547449
- ParkerNTurkMJWestrickELewisJDLowPSLeamonCPFolate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assayAnal Biochem2005338228429315745749
- AssarafYGLeamonCPReddyJAThe folate receptor as a rational therapeutic target for personalized cancer treatmentDrug Resist Updat2014174–6899525457975
- HuYWangYJiangJPreparation and characterization of novel perfluorooctyl bromide nanoparticle as ultrasound contrast agent via layer-by-layer self-assembly for folate-receptor-mediated tumor imagingBiomed Res Int20162016638146427652265
- LiKLiuYZhangSFolate receptor-targeted ultrasonic PFOB nanoparticles: synthesis, characterization and application in tumor-targeted imagingInt J Mol Med20173961505151528487935
- TranTDCaruthersSDHughesMClinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeuticsInt J Nanomedicine20072451552618203420
- WinterPMPerfluorocarbon nanoparticles: evolution of a multimodality and multifunctional imaging agentScientifica (Cairo)2014201474657425024867
- CastroCIBricenoJCPerfluorocarbon-based oxygen carriers: review of products and trialsArtif Organs201034862263420698841
- KanedaMMSasakiYLanzaGMMilbrandtJWicklineSAMechanisms of nucleotide trafficking during siRNA delivery to endothelial cells using perfluorocarbon nanoemulsionsBiomaterials201031113079308620092889
- LanzaGMYuXWinterPMTargeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosisCirculation2002106222842284712451012
- LeeSJSchlesingerPHWicklineSALanzaGMBakerNAInteraction of melittin peptides with perfluorocarbon nanoemulsion particlesJ Phys Chem B201111551152711527922050303
- PanDPhamCTWeilbaecherKNTomassonMHWicklineSALanzaGMContact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug deliveryWiley Interdiscip Rev Nanomed Nanobiotechnol2016818510626296541
- LeeSJSchlesingerPHWicklineSALanzaGMBakerNASimulation of fusion-mediated nanoemulsion interactions with model lipid bilayersSoft Matter20128263024303522712024
- ZhouHFHuGWicklineSALanzaGMPhamCTSynergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritisNanomedicine (Lond)2010571065107420874021
- ZhouHFYanHSenpanASuppression of inflammation in a mouse model of rheumatoid arthritis using targeted lipase-labile fumagillin prodrug nanoparticlesBiomaterials201233338632864022922023
- TomlinsonREMcKenzieJASchmiederAHWohlGRLanzaGMSilvaMJAngiogenesis is required for stress fracture healing in ratsBone201352121221923044046
- TomlinsonRESchmiederAHQuirkJDLanzaGMSilvaMJAntagonizing the alphav beta3 integrin inhibits angiogenesis and impairs woven but not lamellar bone formation induced by mechanical loadingJ Bone Mine Res201429919701980
- LanzaGMJenkinsJSchmiederAHAnti-angiogenic nanotherapy inhibits airway remodeling and hyper-responsiveness of dust mite triggered asthma in the Brown Norway ratTheranostics20177237738928042341
- JalloukAPMoleyKHOmurtagKNanoparticle incorporation of melittin reduces sperm and vaginal epithelium cytotoxicityPLoS One201494e9541124748389
- PhamCTThomasDGBeiserJApplication of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticlesNanomedicine201410365166024211337
- MarshJNSenpanAHuGFibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysisNanomedicine (Lond)20072453354317716136
- MarshJNHuGScottMJA fibrin-specific thrombolytic nanomedicine approach to acute ischemic strokeNanomedicine (Lond)20116460561521506686
- CyrusTZhangHAllenJSIntramural delivery of rapamycin with alphavbeta3-targeted paramagnetic nanoparticles inhibits stenos is after balloon injuryArterioscler Thromb Vasc Biol200828582082618292395
- WongHLBendayanRRauthAMLiYWuXYChemotherapy with anticancer drugs encapsulated in solid lipid nanoparticlesAdv Drug Deliv Rev200759649150417532091
- DinFUAmanWUllahIEffective use of nanocarriers as drug delivery systems for the treatment of selected tumorsInt J Nanomedicine2017127291730929042776
- WangHLuZWangLNew generation nanomedicines constructed from self-assembling small molecule prodrugs alleviate cancer drug toxicityCancer Res201777246963697429055017
- MishraBPatelBBTiwariSColloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug deliveryNanomedicine20106192419447208
- HowCWRasedeeAManickamSRosliRTamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicityColloids Surf B Biointerfaces201311239339924036474
- SomanNRBaldwinSLHuGMolecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growthJ Clin Invest200911992830284219726870
- FrechouMBeray-BerthatVRaynaudJSDetection of vascular cell adhesion molecule-1 expression with USPIO-enhanced molecular MRI in a mouse model of cerebral ischemiaContrast Media Mol Imaging20138215716423281288
- BurteaCBalletSLaurentSDevelopment of a magnetic resonance imaging protocol for the characterization of atherosclerotic plaque by using vascular cell adhesion molecule-1 and apoptosis-targeted ultrasmall superparamagnetic iron oxide derivativesArterioscler Thromb Vasc Biol2012326e36e4822516067
- PanHMyersonJWHuLProgrammable nanoparticle functionalization for in vivo targetingFASEB J201327125526423047896
- GalkinaELeyKVascular adhesion molecules in atherosclerosisArterioscler Thromb Vasc Biol200727112292230117673705
- O’HanlonDMFitzsimonsHLynchJTormeySMaloneCGivenHFSoluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinomaEur J Cancer200238172252225712441261
- CrossinKLEdelmanGMSpecific binding of cytotactin to sulfated glycolipidsJ Neurosci Res19923346316381282934
- Chiquet-EhrismannRChiquetMTenascins: regulation and putative functions during pathological stressJ Pathol2003200448849912845616
- PanDKimBHuGA strategy for combating melanoma with oncogenic c-Myc inhibitors and targeted nanotherapyNanomedicine (Lond)201510224125125600969
- SoodguptaDPanDCuiGSmall molecule MYC inhibitor conjugated to integrin-targeted nanoparticles extends survival in a mouse model of disseminated multiple myelomaMol Cancer Ther20151461286129425824336
- SongGLiangCYiXPerfluorocarbon-loaded hollow Bi2Se3 nanoparticles for timely supply of oxygen under near-infrared light to enhance the radiotherapy of cancerAdv Mater201628142716272326848553
- BoissenotTFattalEBordatAPaclitaxel-loaded PEGylated nanocapsules of perfluorooctyl bromide as theranostic agentsEur J Pharm Biopharm201610813614427594209
- ShaoKHuangRLiJAngiopep-2 modified PE-PEG based polymeric micelles for amphotericin B delivery targeted to the brainJ Control Release2010147111812620609375
- RuanSYuanMZhangLTumor microenvironment sensitive doxorubicin delivery and release to glioma using angiopep-2 decorated gold nanoparticlesBiomaterials20153742543525453970
- HuangSLiJHanLDual targeting effect of Angiopep-2-modified, DNA-loaded nanoparticles for gliomaBiomaterials201132286832683821700333
- XinHJiangXGuJAngiopep-conjugated poly(ethylene glycol)-co-poly(epsilon-caprolactone) nanoparticles as dual-targeting drug delivery system for brain gliomaBiomaterials201132184293430521427009
- LuoZJinKPangQOn-demand drug release from dual-targeting small nanoparticles triggered by high-intensity focused ultrasound enhanced glioblastoma-targeting therapyACS Appl Mater Interfaces2017937316123162528861994
- AdamsRHAlitaloKMolecular regulation of angiogenesis and lymphangiogenesisNat Rev Mol Cell Biol20078646447817522591
- LiJLHarrisALCrosstalk of VEGF and Notch pathways in tumour angiogenesis: therapeutic implicationsFront Biosci20091430943110
- FolkmanJAngiogenesis and apoptosisSemin Cancer Biol200313215916712654259
- KooimanKFoppen-HarteveldMvan der SteenAFde JongNSonoporation of endothelial cells by vibrating targeted microbubblesJ Control Release20111541354121514333
- KiesslingFFokongSBzylJLederleWPalmowskiMLammersTRecent advances in molecular, multimodal and theranostic ultrasound imagingAdv Drug Deliv Rev201472152724316070
- PochonSTardyIBussatPBR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesisInvest Radiol2010452899520027118
- SchmiederAHCaruthersSDZhangHThree-dimensional MR mapping of angiogenesis with alpha5beta1(alpha nu beta3)-targeted theranostic nanoparticles in the MDA-MB-435 xenograft mouse modelFASEB J200822124179418918697838
- WinterPMSchmiederAHCaruthersSDMinute dosages of alpha(nu)beta3-targeted fumagillin nanoparticles impair Vx-2 tumor angiogenesis and development in rabbitsFASEB J20082282758276718362202
- EsserAKSchmiederAHRossMHDual-therapy with alphavbeta3-targeted Sn2 lipase-labile fumagillin-prodrug nanoparticles and zoledronic acid in the Vx2 rabbit tumor modelNanomedicine201612120121126515754
- PanDSchmiederAHWangKAnti-angiogenesis therapy in the Vx2 rabbit cancer model with a lipase-cleavable Sn 2 taxane phospholipid prodrug using alpha(v)beta(3)-targeted theranostic nanoparticlesTheranostics20144656557824723979
- MorenoPRPurushothamanKRFusterVPlaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerabilityCirculation2004110142032203815451780
- MorenoPRPurushothamanKRSirolMLevyAPFusterVNeovascularization in human atherosclerosisCirculation2006113182245225216684874
- McCarthyMJLoftusIMThompsonMMAngiogenesis and the atherosclerotic carotid plaque: an association between symptomatology and plaque morphologyJ Vasc Surg199930226126810436445
- JainRKFinnAVKolodgieFDGoldHKVirmaniRAntiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilizationNat Clin Pract Cardiovasc Med20074949150217712362
- WinterPMMorawskiAMCaruthersSDMolecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticlesCirculation2003108182270227414557370
- WinterPMNeubauerAMCaruthersSDEndothelial alpha(v) beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosisArterioscler Thromb Vasc Biol20062692103210916825592
- WinterPMCaruthersSDZhangHWilliamsTAWicklineSALanzaGMAntiangiogenic synergism of integrin-targeted fumagillin nanoparticles and atorvastatin in atherosclerosisJACC Cardiovasc Imaging20081562463419356492
- KanedaMMCaruthersSLanzaGMWicklineSAPerfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeuticsAnn Biomed Eng200937101922193319184435
- SchmiederAHWinterPMCaruthersSDMolecular MR imaging of melanoma angiogenesis with alphanubeta3-targeted paramagnetic nanoparticlesMagn Reson Med200553362162715723405
- WinterPMCaruthersSDKassnerAMolecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu) beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imagingCancer Res200363185838584314522907
- GanauMSyrmosNCD’ArcoFEnhancing contrast agents and radiotracers performance through hyaluronic acid-coating in neuroradiology and nuclear medicineHell J Nucl Med2017202166168
- LiangXFangLLiXZhangXWangFActivatable near infrared dye conjugated hyaluronic acid based nanoparticles as a targeted theranostic agent for enhanced fluorescence/CT/photoacoustic imaging guided photothermal therapyBiomaterials2017132728428411450
- GanauMTackling gliomas with nanoformulated antineoplastic drugs: suitability of hyaluronic acid nanoparticlesClin Transl Oncol201416222022324072561
- RapoportNPhase-shift, stimuli-responsive perfluorocarbon nanodroplets for drug delivery to cancerWiley Interdiscip Rev Nanomed Nanobiotechnol20124549251022730185
- KeXLinWLiXWangHXiaoXGuoZSynergistic dual-modified liposome improves targeting and therapeutic efficacy of bone metastasis from breast cancerDrug Deliv20172411680168929092646
- YangYWangKGuXLeongKWBiophysical regulation of cell behavior-cross talk between substrate stiffness and nanotopographyEngineering (Beijing)201731365429071164
- WangKHeXLinthicumWCarbon nanotubes induced fibrogenesis on nanostructured substratesEnviron Sci Nano20174368969928944063
- WangKBruceAMezanRNanotopographical modulation of cell function through nuclear deformationACS Appl Mater Interfaces2016885082509226844365
- SongLWangKLiYYangYNanotopography promoted neuronal differentiation of human induced pluripotent stem cellsColloids Surf B Biointerfaces2016148495827591570